Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

GYREGYRE
9 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in GYRE THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 184,286 shares of GYRE (GYRE THERAPEUTICS INC), worth $1.2M as of 2026-Q2. The position was increased (+11.5% shares). GYRE represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$1.2M

Current Shares

184,286

Total Value Change

+$938,969

Total Shares Change

+161,195

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
184,286
+11.5%
$1.2M0.0%$6.59
28
2026-Q1
Decreased
165,238
-2.3%
$1.2M0.0%$7.90
0
2025-Q4
Increased
169,158
+37.1%
$1.2M0.0%$7.02
33
2025-Q3
Decreased
123,386
-4.7%
$920,4600.0%$7.50
0
2025-Q2
Increased
129,420
+16.2%
$951,2370.0%$7.42
29
2025-Q1
Decreased
111,416
-2.8%
$860,1320.0%$9.11
0
2024-Q4
Increased
114,566
+0.8%
$1.4M0.0%$12.66
26
2024-Q3
Increased
113,648
+392.2%
$1.4M0.0%$12.76
41
2024-Q2
New
23,091
-
$275,4760.0%$11.93
32

Other major holders of GYRE: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used